Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan Shimon

Showing results (121-130 of 196) with videos related to

Pageof 20
Sort By:
Pain Research & Management|April 21, 2012
Evaluation of leptin levels among fibromyalgia patients before and after three months of treatment, in comparison with healthy controlsJacob Nadav Ablin, Natalya Aronov, Ilan Shimon, et al.
Molecular and Cellular Endocrinology|April 29, 2014
IGF1 induces cell proliferation in human pituitary tumors - functional blockade of IGF1 receptor as a novel therapeutic approach in non-functioning tumorsHadara Rubinfeld, Adi Kammer, Ortal Cohen, et al.
Pituitary|September 24, 2014
Pituitary imaging findings in male patients with hypogonadotrophic hypogonadismDania Hirsch, Carlos Benbassat, Yoel Toledano, et al.
The Journal of Clinical Endocrinology and Metabolism|August 27, 2014
Papillary thyroid cancer: factors involved in restaging N1 disease after total thyroidectomy and radioactive iodine treatmentAdi Guy, Dania Hirsch, Tzippy Shohat, et al.
Endocrine-Related Cancer|June 9, 2025
Predictors of cancer in patients with endogenous Cushing's syndromeYaron Rudman, Genady Drozdinsky, Hiba Masri-Iraqi, et al.
Pituitary|May 6, 2018
IGF-1 levels may increase paradoxically with dopamine agonist treatment for prolactinomasAmit Akirov, Yona Greenman, Benjamin Glaser, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 19, 2019
LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASESOmer Slook, Sigal Levy, Ilana Slutzky-Shraga, et al.
Journal of Endocrinological Investigation|October 30, 2024
Breast Cancer risk in patients with dopamine agonist-treated hyperprolactinemiaLaura Dery, Ilan Shimon, Yaron Rudman, et al.
Endocrine Research|November 7, 2015
Prevalence and clinical characteristics of adrenal incidentalomas in potential kidney donorsAlon Grossman, Ronit Koren, Amit Tirosh, et al.
Frontiers in Endocrinology|April 5, 2021
Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing DiseaseAmit Akirov, Vincent Larouche, Ilan Shimon, et al.
Pageof 20

Showing results (121-130 of 196) with videos related to

Sort By:
Pageof 20
Pain Research & Management|April 21, 2012
Evaluation of leptin levels among fibromyalgia patients before and after three months of treatment, in comparison with healthy controlsJacob Nadav Ablin, Natalya Aronov, Ilan Shimon, et al.
Molecular and Cellular Endocrinology|April 29, 2014
IGF1 induces cell proliferation in human pituitary tumors - functional blockade of IGF1 receptor as a novel therapeutic approach in non-functioning tumorsHadara Rubinfeld, Adi Kammer, Ortal Cohen, et al.
Pituitary|September 24, 2014
Pituitary imaging findings in male patients with hypogonadotrophic hypogonadismDania Hirsch, Carlos Benbassat, Yoel Toledano, et al.
The Journal of Clinical Endocrinology and Metabolism|August 27, 2014
Papillary thyroid cancer: factors involved in restaging N1 disease after total thyroidectomy and radioactive iodine treatmentAdi Guy, Dania Hirsch, Tzippy Shohat, et al.
Endocrine-Related Cancer|June 9, 2025
Predictors of cancer in patients with endogenous Cushing's syndromeYaron Rudman, Genady Drozdinsky, Hiba Masri-Iraqi, et al.
Pituitary|May 6, 2018
IGF-1 levels may increase paradoxically with dopamine agonist treatment for prolactinomasAmit Akirov, Yona Greenman, Benjamin Glaser, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 19, 2019
LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASESOmer Slook, Sigal Levy, Ilana Slutzky-Shraga, et al.
Journal of Endocrinological Investigation|October 30, 2024
Breast Cancer risk in patients with dopamine agonist-treated hyperprolactinemiaLaura Dery, Ilan Shimon, Yaron Rudman, et al.
Endocrine Research|November 7, 2015
Prevalence and clinical characteristics of adrenal incidentalomas in potential kidney donorsAlon Grossman, Ronit Koren, Amit Tirosh, et al.
Frontiers in Endocrinology|April 5, 2021
Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing DiseaseAmit Akirov, Vincent Larouche, Ilan Shimon, et al.
Pageof 20